Alternative indications for pulsatile gonadotropin-releasing hormone therapy in infertile women.
Three groups of women with different types of ovulatory dysfunction who had failed to conceive on conventional therapy were treated with pulsatile gonadotropin-releasing hormone (GnRH). Group A consisted of nine patients with luteal phase defect; group B included four patients with apparently normal menstrual cycles but disordered folliculogenesis seen by serial ultrasound examinations; and group C consisted of eight patients who exhibited anovulation or irregular ovulation. GnRH was administered subcutaneously or intravenously in dosages varying from 5 micrograms to 20 micrograms, with pulse frequency of 2 to 3 hours in 53 cycles. Forty-one cycles were ovulatory. Four pregnancies resulted, one ending in miscarriage at 12 weeks' gestation. Our results indicate that GnRH may be used as an alternative to the prevalent therapeutic methods for ovulatory dysfunction. Only those women who had anovulation and abnormal basal levels of serum luteinizing hormone were resistant to GnRH therapy.
D000328:Adult; D000858:Anovulation / Q000188:drug therapy; D002582:Cervix Mucus / Q000187:drug effects; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000627:therapeutic use*; D006801:Humans; D007247:Infertility, Female / Q000188:drug therapy*; D008183:Luteal Phase; D008596:Menotropins / Q000627:therapeutic use; D008599:Menstruation Disturbances / Q000188:drug therapy; D011247:Pregnancy; D013997:Time Factors
D007987:Gonadotropin-Releasing Hormone; D008596:Menotropins